Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Vasteras

40 clinical trials in Vasteras, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Vasteras at a glance
40
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

40 trials in Vasteras

Open in trial search

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Eli Lilly & Co.

A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:AZD5148
  • Sponsor:AstraZeneca AB

Study of Continuous Infusion of Cloxacillin Using Elastomeric Pump in Adult Patients with Staphylococcus Aureus Infection

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cloxacillin Sodium

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Region Stockholm

Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Bleomycin
  • Sponsor:St. Olavs Hospital HF

Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska Institutet

Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Karolinska Institutet

Study Comparing Benzylpenicillin and Cloxacillin for Treating Staphylococcus Aureus Blood Infection in Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cloxacillin
  • Sponsor:Region Skane

Glioblastoma

Recruiting

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Vasteras

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on atherosclerotic cardiovascular disease prevention and treatment, including studies of novel medications for stroke prevention and heart failure management.

  • Acute ischemic stroke treatment
  • Heart failure with preserved ejection fraction
  • Prevention of cardiovascular events

Several studies are evaluating new therapeutic approaches to reduce major adverse cardiovascular events in high-risk patients.

02 Oncology Studies

Comprehensive research in breast cancer treatments, including trials for both early-stage and metastatic disease, plus studies in testicular cancer management.

  • Triple-negative breast cancer
  • Hormone receptor-positive breast cancer
  • Colorectal cancer treatment

Advanced therapeutic approaches are being tested to improve patient outcomes across various cancer types.

03 Infectious Diseases

Research focusing on viral lung infections and bacterial infections, including innovative treatments for severe respiratory conditions.

  • Severe viral lung infections
  • Bacterial infections
  • HPV prevention and screening

Studies aim to evaluate new therapeutic interventions and prevention strategies for various infectious diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.